Introduction
Voltage-gated calcium channels (VGCCs) are key components in the pathogenesis of various forms of epilepsy [1] . Recently, we could demonstrate that Ca v 2.3 E-/Rtype Ca 2+ channels are important in modulating absence epilepsy [2] , a pathophysiological aberration of the thalamocortical oscillations that are related to slowwave sleep (SWS) [3, 4] . During the last decade, several reports have discussed the intimate relationship between sleep and epilepsy. Even Aristotle noted that "sleep is like epilepsy and epilepsy is like sleep" (cited in [5] ). Epilepsy and sleep both represent states of the brain. However, while sleep is a normal physiological event, epileptic seizures are of pathophysiological origin. Critical comparison of both states has led to a more careful distinction between them [6] , particularly in relation to the underlying mechanisms of the thalamocortical oscillations observed during electroencephalogram (EEG) recordings, for which some common features were initially discussed [6, 7] . Differential origins of sleep spindles and spike-andwave discharges (SWDs) were identified [6] , which led to the conclusion that an understanding of the underlying mechanisms involved-in which the thalamus and the thalamocortical network play a central role [9] -will require a detailed description of sleep-related ion channels, transporters [8] and transmitter receptors.
Shortly after the cloning of T-type VGCCs, their neuronal distribution was determined by in situ hybridization [10] . The transcripts of each of the three T-type Ca 2+ channels had a unique distribution in the central nervous system, particularly in the thalamus and the thalamic reticular nucleus (nRt), and their patterns of expression were largely complementary. As T-type Ca 2+ channels affect afterpotential properties and excitability in neurons [11] , their distribution was also determined in the Genetic Absence Epilepsy Rats from Strasbourg (GAERS). In addition to expression of Ca v 3.1 (alpha1G), Ca v 3.2 (alpha1H) and Ca v 3.3 (alpha1I), transcripts for Ca v 2.3 (alpha1E) were also analyzed [12] . Compared to non-epileptic control rats, juvenile GAERS rats display higher amplitude T-type Ca 2+ currents in neurons of the nRt. Transcripts of Ca v 2.3, which should be considered a mid-voltage-gated Ca 2+ channel, did not differ between the two animal groups. This led to the conclusion that Ca v 2.3 may not contribute to the pathological thalamocortical oscillations characteristically found in GAERS rats. However, in another study using quantitative reverse transcription (RT)-PCR and in situ hybridization, reduced Ca v 2.3 levels were found in the cerebellum and brain stem of GAERS rats compared to non-epileptic animals [13] . No difference was found in younger animals lacking the GAERS epileptic phenotype and no difference was recorded for Ca v 3.1 transcripts.
As important as T-type Ca 2+ channels are in epileptogenesis, they are also crucial for the regulation of sleep and wakefulness. T-type Ca 2+ channels contribute substantially to the oscillatory output of the thalamus region [14, 15, 16, 17, 18] . Although it is well known that all three Ca v 3 T-type Ca 2+ channels are complementarily expressed in the thalamocortical system, their respective distinct contributions to sleep have yet to be fully described. In the nRt, the Ca v 3.3 T-type Ca 2+ channel is expressed abundantly, similarly to Ca v 2.3 E-/R-type channels. Consequently, inactivation of Ca v 3.3 causes a disturbance in the synchronized thalamic network oscillations underlying sleep-spindle waves. These were markedly weakened because of a reduced inhibition of the thalamocortical neurons by the nRt cells, confirming the central role of Ca v 3.3 T-type channels in rhythmogenesis of the sleep-spindle generator [19] .
Although it was believed that high-voltage-activated Ca 2+ channels may not be involved in seizure processes in rat models of absence epilepsy, recent evidence from Ca v 2.3-deficient mice suggests their involvement in the murine model [20] . Recordings from tissue slices revealed that neurons of the reticular thalamus (RT) display oscillatory discharges, which are believed to be critical for thalamocortical network oscillations related to absence epilepsy. In brain slices from Ca v 2.3-deficient mice, injection of hyperpolarizing currents initiated a low-threshold burst of spikes in RT neurons. However, subsequent oscillatory burst discharges were severely sup-pressed and accompanied by significantly reduced slow afterhyperpolarization (AHP), suggesting that not only T-type Ca 2+ channels, but also mid-voltage-gated Ca v 2.3 E-/R-type channels contribute to oscillatory burst discharges in RT neurons. Ca v 2.3 (highly expressed in the nRt) may cooperate with the T-type Ca 2+ channels expressed in the same or different neurons of the thalamocortical loop, which is part of a common neuronal network for sleep spindles and SWDs [21] .
Since the thalamocortical network is connected to absence epilepsy [2, 22] and sleep [9, 23] , the present study was undertaken to elucidate the role of the Ca v 2.3 VGCC in rodent sleep. Sleep architecture was investigated in control and Ca v 2.3(−|−) mice using implantable EEG/electromyography (EMG) radiotelemetry in a spontaneous 24 h sleep paradigm and pharmacologically (urethane)-induced sleep.
Materials and methods

Chemicals
All chemicals were analytical grade. Urethane (>99% purity) was obtained from Sigma-Aldrich (Steinheim, Germany) and dissolved in 0.9% (w/v) NaCl solution. The mean body weight of the six mice used from each genotype was 32.5±1.0 g for control mice and 32.7±2.2 g for Ca v 2.3-deficient animals. Mice from both genotypes were age-matched at the day of implantation (age was 161±5 days for controls and 164±10 days for Ca v 2.3-deficient mice). Mice were used for EEG recordings after 10-12 days of implantation.
Study animals
All animal experimentation was approved by the local institutional committee on animal care. All efforts were made to minimize animal suffering and to use the minimum number of animals required to produce reliable scientific data.
Telemetric EEG recordings
The telemetry system, anesthesia, implantation procedure and postoperative treatment have been described in detail previously [26] . The positive electrode of the F20-EET transmitter (DSI, St. Paul, MN, USA) was implanted over the primary somatosensory cortex (−1 mm caudally, −3 mm laterally from bregma) and the negative electrode over the cerebellum (−6.3 mm caudally, −1 mm laterally from bregma). Electrodes from the second channel of the transmitter were implanted into the trapezius muscle. Mice were allowed 10-12 days to recover from surgery before radiotelemetric EEGs and EMGs [26] were recorded from six freely moving Ca v 2.3-deficient and six control mice over a 24 h period to permit recording of spontaneous sleep. Thereafter, pharmacologically-induced sleep was invoked by systemic intraperitoneal (i.p.) administration of 800 mg urethane/kg body weight, which was followed up by EEG/EMG recording for 24 h. Because urethane develops its maximum effect within 30 min after injection, the first 60 min after injection were selected for the evaluation of sleep stage. During induced sleep, mice were placed on a heating plate to maintain proper body temperature.
Dataquest™ A.R.T.™ 3.1 software (DSI) was used to record EEGs, which were sampled at 1000 Hz without filtering. Neuroscore 2.1.0 (DSI) was used to calculate the absolute and relative power of frequency bands (fast Fourier transform based using a Hamming window). The frequency spectrum was defined as follows: δ: 0.5-4 Hz, θ: 4-8 Hz, α: 8-12 Hz, β: 16-24 Hz. The rodent sleep scoring analysis protocol assigned a vigilance stage to each epoch based on EEG, EMG and activity data. Accordingly, the sleep stages were grouped into: "active wake", "quiet wake", "paradoxical sleep" (PS), "slow-wave sleep 1" (SWS1) and "slow-wave sleep 2" (SWS2). "Total sleep time" is the time from sleep onset until the last wake episode, excluding wakefulness occurring in that interval. "Wake time after sleep onset" (WASO) is the summed wake time occurring within the sleep period. "Sleep onset" is the duration from start of scoring until the first occurrence of sleep stages (PS or SWS). "PS onset" is the duration from start of scoring until the first occurrence of PS. "SWS onset" is the duration from start of scoring until the first occurrence of SWS.
The active wake stage was scored when muscle tone was high and movements of the mice were between low and high. PS was recognized by a dominant θ power band and an increase in the θ/δ ratio. A dominant δ component is significant for SWS (i.e. deep sleep) and when the ratio of 
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Telemetrie · Elektroenzephalographie · Langsame-Wellen-Schlaf · REM-Schlaf · Ionenkanal δ power to total power exceeds the threshold of 0.35, SWS2 is awarded, otherwise SWS1. The EMG threshold was lowered from 20 to 10 μV to ensure a more sensitive detection of movements. In four randomly picked mice (two of each genotype), the accuracy of the automatic sleep scoring protocol was assessed by manually determining REM and NREM sleep according to classic EEG definitions and evaluating the level of activity (locomotion) independently of EMG. In these evaluated cases, we found the automated protocol to be comparable to classic definitions of NREM and REM sleep and therefore suitable for comparison of sleep parameters in this study.
Spectral analysis was performed on the first clearly distinguishable full sleep cycle of the 24 h recording of spontaneous sleep performed for each mouse. A sleep cycle was defined as an episode of all three sleep stages (SWS1, SWS2 and PS), bordered by at least 1 min of active wakefulness. The average relative power of the frequency bands δ, θ, α and β was computed for the three sleep stages and compared between the two genotypes.
Statistical analysis
Data are displayed as mean ± SEM. The distribution of relative spectral power was assessed using the Shapiro-Wilk test of normality and found to be mostly nonnormally distributed. Therefore, relative power values were log transformed (log(x/ (1-x))) to obtain a more Gaussian distribution, before being subjected to analysis of variance (ANOVA) [27] . Statistical comparison was performed for the data in . Fig. 4 and . Fig. 5 using the student t-test, with p<0.05 considered as significant (*) and p<0.01 as highly significant (**). For the parameters of total sleep time, WASO and active wake (. Fig. 1, 2, 3, 4) , the denoted values were certified with the Levene's test for equality of variances and represent assumed variances. The MannWhitney U test verified the significances for the duration of SWS2, the SWS2-PS transition and the single longest active wake and SWS2 sleep stages.
Results
Analysis of duration and latencies of sleep stages during the 24 h spontaneous sleep
Telemetric EEG recordings of normal and urethane-induced sleep reveal no obvious differences between Ca v 2.3-competent (. Fig. 1a and c) and Ca v 2.3-deficient mice (. Fig. 1b and d ) during short 30 s recordings from SWS periods. However, differences between the genotypes became evident when evaluating the total recording periods (24 h for normal sleep and 60 min for urethane-induced sleep).
During the 24 h of spontaneous sleep/ wakefulness activity, WASO, sleep onset and PS onset were comparable between both genotypes (. Fig. 2 ), however the total sleep time of control animals (910±127 min) was significantly longer (p=0.039) than that of Ca v 2.3(−|−) mice (597±36 min, compare the mean values labeled by an asterix in . Fig. 2a and c) . As depicted in . Fig. 3 , the duration of sleep stages quiet wake, PS and SWS1 did not differ between the two genotypes, however control animals exhibit significantly shorter (p=0.043) active wake periods (501±133 min) compared to Ca v 2.3-defi- cient mice (821±38 min). SWS2 was significantly longer in control (503±43 min, . Fig. 3a) than Ca v 2.3 knockout (KO) mice (227±44 min, p=0.001 . Fig. 3b) . Correspondingly, Ca v 2.3(−|−) mice exhibited the longest single active wake (p=0.015) and the shortest SWS2 stage (p=0.002, . Fig. 3b) . Furthermore, the number of transitions from SWS2 to PS shows a significant difference between the genotypes (controls: 16±5 vs. Ca v 2.3-KO: 2±1, p=0.022), while all other transitions were comparable between both genotypes. Noticeably, a high scatter was found in control animals for total sleep time, WASO and active wake (. Fig. 2 and . Fig. 3 ). In conclusion, ablation of Ca v 2.3 disturbs normal sleep behavior in adult male mice by shortening SWS2 and total sleep time, which is logically accompanied by an increase in active wake time in Ca v 2.3-deficient mice.
Spectral analysis of spontaneous sleep
Spectral analysis of the first sleep cycle revealed significant differences in the spectral distributions of the two genotypes during all three sleep stages (. Fig. 4a ). During both SWS stages, Ca v 2.3-KO mice display significantly less relative δ power compared to controls, potentially representing reduced depth of NREM sleep (. Fig. 4b , left and middle panels). During SWS and PS, Ca v 2.3-KO mice display significantly increased relative θ power compared to control mice, reflected by the decrease in other frequency bands (. Fig. 4b ). Interestingly, although Ca v 2.3-KO mice appear to sleep less, they do not display increased δ power that would reflect a greater intensity of SWS.
Urethane-induced sleep
For the evaluation of urethane-induced sleep, the first 60 min after injection of urethane were selected, since urethane develops its maximum effect 30 min after injection. As shown in . Fig. 5 , during urethane-induced, i.e. artificial sleep, total sleep time was significantly longer in control animals (p=0.034). The duration of active wake is increased in Ca v 2.3(−|−) mice (controls: 7±2 min vs. Ca v 2.3-KO: 22±6 min; p=0.027). Furthermore, a significant difference in the duration of PS was observed between both genotypes (controls: 1.4±1.5 vs. Ca v 2.3-KO: 0.03±0.08 min; p=0.048). In contrast, no difference was found between the two genotypes in the duration of deep sleep (SWS2) (controls: 45±2 min vs. Ca v 2.3-KO 35±6 min; student's t-test p=0.16). SWS1 comparisons were also equal. The number of transitions from active wake to quiet wake was significantly increased in Ca v 2.3-KO mice (p=0.022). Furthermore, the maximum single active stage duration is also increased in control animals (p=0.008). The Mann-Whitney U test verified the significances for the total sleep time, sleep onset, SWS onset, duration of active wake and PS and the active wake-quiet wake transition. Interestingly, the scatter is higher in the Ca v 2.3(−|−) mice group, whereas controls exhibit homogeneous values (for all p-values: two-tailed t-test with n=6 and significance level p<0.05). The results for urethane-induced sleep are summarized and compared to normal sleep (. Fig. 5 ).
Discussion
The observed differences in sleep architecture mainly affected the duration (. Fig. 5 ) and intensity of deep NREM sleep (. Fig. 4) . The number of transitions from SWS2 to PS during 24 h, as well as the duration of SWS2 and PS implicate Ca v 2.3 E-/R-type Ca 2+ channels as modulators of thalamocortical signal transduc- tion. Duration, timing and depth of sleep are regulated by two interacting processes: a homeostatic factor (which regulates depth and duration of sleep), within a circadian rhythm (which is the factor that determines the timing of sleep) [28] . While slow-wave activity is mainly not influenced by circadian factors, the intensity of δ waves in deep sleep stages and the propensity to sleep are both proportional to the duration of prior wakefulness [29, 30] . Sleep homeostasis is therefore dependent on the interval since the last sleep episode and the depth of this sleep. Remarkably, although Ca v 2.3-KO mice sleep less and therefore endure longer periods of wakefulness, they do not exhibit deeper sleep, indicating disturbances in sleep homeostasis and therefore a role of Ca v 2.3 calcium channels in sleep homeostasis.
As recently summarized for other regions and species [33] , murine Ca v 2.3 VGCCs are expressed in most basal ganglia regions, the thalamus, the hypothalamus, the amygdala, the hippocampus and the cortex [31, 32] . Two major splice variants exist in the central nervous system [34] ; one being unique to the cerebellum [35] . On the protein level, Ca v 2.3 has been identified in the nRt region, the neocortex and the hippocampus [34] . Thus, Ca v 2.3 is expressed in regions that are known to contribute to the modulation of the thalamocortical network.
Humans and animals spend a third of their lives asleep. However, we have yet to fully understand why sleep is necessary. Although it is evident that it is mainly the brain that requires sleep, the main Sleep induction and the increasing depth of NREM sleep measured as slow oscillations are proposed to result from the inhibition of the thalamic relay nuclei mediated by the nRt, where Ca v 2.3 is highly expressed [12] . A finely tuned interplay between GABAergic inhibitory postsynaptic potentials received from nRt neurons and two types of voltage-gated channels (T-type Ca 2+ channels and hyperpolarization-activated cation channels) modulates the activity of thalamocortical projections [36] . Besides this interplay, additional changes in conductance contribute to such oscillations as well [37, 38] . Recently, a T-type Ca 2+ channel has been connected to the initiation of synchronized thalamic network oscillations underlying sleep spindle waves: deletion of Ca v 3.3 markedly weakened (but did not abrogate) thalamic network oscillations suggesting a central role for Ca v 3.3 VGCCs in the rhythmogenic properties of the sleep spindle generator [39] . One may postulate that Ca v 2.3 could contribute to such a regulation, since both channels are expressed in the nRt region. Repetitive burst firing in nRt neurons was also shown to be dependent on intracellular Ca 2+ homeostasis, which is affected by several mechanisms and actions of transporters and ion channels [8, 40] . The use of γ-butyrolactone to induce absence epilepsy in two Ca v 2.3-deficient mouse models has led to opposite conclusions regarding to the ability to induce absence epilepsy [2, 41] . In brain slices from Ca v 2.3-deficient mice, injection of hyperpolarizing current initiated low-threshold bursts of spikes in nRt neurons. However, subsequent oscillatory burst discharges were severely suppressed in Ca v 2.3-deficient mice, with a significantly reduced slow AHP [41] .
In our own model of Ca v 2.3-deficient mice, we investigated absence-specific SWD susceptibility by systemic administration of γ-hydroxybutyrolactone followed by electrocorticographic radiotelemetric recordings, behavioral analysis and histomorphological characterization. Based on motoric studies, SWD and power-spectrum density (PSD) analysis, our results demonstrated that Ca v 2.3-deficient mice exhibit increased absence seizure susceptibility [2] . So far, the discrepancy between the different mouse knockout models is unclear. However thalamocortical rhythmicity is altered in both models as compared to the corresponding control mouse line.
Furthermore, spectral analysis revealed differences between both genotypes during REM (PS) sleep. Interestingly, SNX-482-a selective antagonist of Ca v 2.3-was found to attenuate carbachol inhibition of somatic spike-evoked calcium transients in the laterodorsal tegmentum (LDT), which projects to the REMinduction site of the brainstem [42] . Because the spike-evoked calcium influx dampens excitability in the LDT, it is conceivable that muscarinic control of Ca v 2.3 regulates firing rate and responsiveness to excitatory inputs during states of high firing, like during REM sleep.
Future studies involving region-specific neuronal inactivation of Ca v 2.3 may help to understand the interplay of ion channels, transporters and signaling receptors that is important for sleep homeostasis. In mice, Ca v 2.3 evidently represents an important participant, as far as it can be concluded from its general ablation.
